Results 231 to 240 of about 92,879 (297)

Design and Analysis of Novel HEV Vaccine Variants and Evaluation of Two Selected Candidates in a Porcine Infection Model. [PDF]

Liver Int
Hrabal I, Aliabadi E, Weber S, Ssebyatika GL, Krey T, Holicki CM, Schmid L, Dinkelborg K, Schröder C, Fast C, Behrendt P, Groschup MH, Eiden M.   +12 more
europepmc   +1 more source

How I Treat: Infections and inborn errors of immunity-Prevention, diagnosis, and treatment. [PDF]

J Hum Immun
Freeman AF, Thielen BK, Pozos TC.
europepmc   +1 more source

Editorial: Research advances and challenges in emerging and re-emerging viral diseases. [PDF]

Front Microbiol
Stufano A, Lanave G, Carnell GW, Trombetta CM.   +3 more
europepmc   +1 more source

General Information on the Vertebrate Virus Data Bank "DAISY" [PDF]

, 1984
Bachmann, P. A., Eichhorn, Werner
core  

Nanocarrier-based immunotherapy for viral diseases. [PDF]

Int J Pharm X
Liu D, Zhao T, Li Y, Huang L, Che J, Zou P, Yang W, Ding J, Wu P, Gao X, Ran Y, Sun H, Li Z, Gao J, Gao C.   +14 more
europepmc   +1 more source

Public health and community support for prevention of novel viral diseases: a qualitative study with LGBTQIA + people and people with blood-borne viruses. [PDF]

BMC Health Serv Res
Drysdale K, Lupton D.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Viral Hepatitis Vaccines

Annual Review of Medicine, 1985
Purified from the plasma of hepatitis B carriers, hepatitis B surface antigen particles have been used in a vaccine to prevent hepatitis B. This plasma-derived vaccine is immunogenic, protective, and has an excellent safety record. Indications and strategies for preexposure and postexposure prophylaxis are reviewed.
I M, Jacobson, J L, Dienstag
openaire   +3 more sources